Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl

Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl

Bibliografske podrobnosti
Main Authors:	Collins, R, Armitage, J, Parish, S, Sleight, P, Peto, R, Col, M
Format:	Journal article
Izdano:	2002

Podobne knjige/članki

Randomized trial of cholesterol-lowering, and of antioxidant vitamins, in 6,000 people with diabetes mellitus
od: Collins, R, et al.
Izdano: (2002)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 5,000 women at high-risk of coronary heart disease
od: Collins, R, et al.
Izdano: (2002)

Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke
od: Collins, R, et al.
Izdano: (2002)

Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl"
od: Brown W Virgil
Izdano: (2001-02-01)

The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.
od: Parish, S, et al.
Izdano: (2009)

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
od: Armitage, J, et al.
Izdano: (2010)

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
od: Collins, R, et al.
Izdano: (2004)

LDL cholesterol targets--how low to go?
od: Bulbulia, R, et al.
Izdano: (2012)

Statin Treatment in Patients With Stroke With Low‐Density Lipoprotein Cholesterol Levels Below 70 mg/dL
od: Joon‐Tae Kim, et al.
Izdano: (2023-09-01)

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial.
od: Bulbulia, R, et al.
Izdano: (2011)

Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathwayss⃞
od: Ming-Dong Wang, et al.
Izdano: (2007-03-01)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
od: John H. Contois, et al.
Izdano: (2023-08-01)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
od: Hopewell, J, et al.
Izdano: (2012)

Quo vadis, LDL cholesterol?
od: Cobos Andrés, et al.
Izdano: (2023-05-01)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
od: Baigent, C, et al.
Izdano: (2010)

LDL particle size and LDL and HDL cholesterol changes with dietary fat and cholesterol in healthy subjects
od: Peter M. Clifton, et al.
Izdano: (1998-09-01)

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
od: Collins, R, et al.
Izdano: (2003)

Comparison of LDL-Cholesterol Estimate using Various Formulae with Directly Measured LDL-Cholesterol in Indian Population
od: Nishtha Wadhwa, et al.
Izdano: (2016-12-01)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
od: Safi U. Khan, et al.
Izdano: (2020-03-01)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
od: Emberson, J, et al.
Izdano: (2012)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
od: Yukihito Higashi
Izdano: (2023-05-01)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
od: Baigent, C, et al.
Izdano: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
od: Baigent, C, et al.
Izdano: (2011)

Addressing dyslipidemic risk beyond LDL-cholesterol
od: Alan R. Tall, et al.
Izdano: (2022-01-01)

Comments on the MRC/BHF Heart Protection Study - Authors' reply
od: Collins, R, et al.
Izdano: (2003)

MRC/BHF Heart Protection Study - Reply
od: Collins, R, et al.
Izdano: (2002)

Heart Protection Study - Reply
od: Collins, R, et al.
Izdano: (2003)

New analyses of Heart Protection Study - Reply
od: Collins, R, et al.
Izdano: (2004)

Beyond LDL cholesterol: remnant cholesterol is associated with cardiometabolic risk factors in children
od: Ana Torres-Costoso, et al.
Izdano: (2025-01-01)

Evaluation of LDL-Cholesterol / HDL-Cholesterol Ratio as Predictor of Dyslipidemia in Subclinical Hypothyroidism
od: Smita S. Kottagi, et al.
Izdano: (2014-01-01)

The effect of adjusting LDL-cholesterol for Lipoprotein(a)-cholesterol on the diagnosis of Familial Hypercholesterolaemia
od: D. Thayabaran, et al.
Izdano: (2022-10-01)

Greater absolute reductions in LDL cholesterol should yield greater proportional reductions in risk of cardiovascular disease.
od: Clarke, R, et al.
Izdano: (2009)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
od: Cholesterol Treatment Trialists' (CTT) Collaboration, et al.
Izdano: (2012-01-01)

Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
od: Armitage, J, et al.
Izdano: (2000)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
od: Aleksandra Gąsecka, et al.
Izdano: (2021-01-01)

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
od: Collins, R, et al.
Izdano: (2002)

Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
od: Zhiyuan Wu, et al.
Izdano: (2023-02-01)

M'siswa baharu tanam 7,000 pokok
od: Universiti Putra Malaysia
Izdano: (2005)

Atasi 7,000 peserta dari 113 negara
od: Hanafi, Khairiyah
Izdano: (2022)

Effects of lowering LDL cholesterol on progression of kidney disease.
od: Haynes, R, et al.
Izdano: (2014)